220 related articles for article (PubMed ID: 17982487)
21. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
23. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
24. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
[TBL] [Abstract][Full Text] [Related]
25. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.
Balakrishnan A; von Neuhoff N; Rudolph C; Kamphues K; Schraders M; Groenen P; van Krieken JH; Callet-Bauchu E; Schlegelberger B; Steinemann D
Genes Chromosomes Cancer; 2006 Oct; 45(10):883-92. PubMed ID: 16830336
[TBL] [Abstract][Full Text] [Related]
26. Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.
Fiskvik I; Aamot HV; Delabie J; Smeland EB; Stokke T; Heim S; Holte H
Eur J Haematol; 2013 Oct; 91(4):332-8. PubMed ID: 23859481
[TBL] [Abstract][Full Text] [Related]
27. TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype.
Zainuddin N; Berglund M; Wanders A; Ren ZP; Amini RM; Lindell M; Kanduri M; Roos G; Rosenquist R; Enblad G
Leuk Res; 2009 Jan; 33(1):60-6. PubMed ID: 18706692
[TBL] [Abstract][Full Text] [Related]
28. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Giphart-Gassler M; Schuuring E; Kluin PM
Genes Chromosomes Cancer; 2002 Sep; 35(1):38-48. PubMed ID: 12203788
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
[TBL] [Abstract][Full Text] [Related]
30. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
31. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
[TBL] [Abstract][Full Text] [Related]
32. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
Pinte S; Guérardel C; Deltour-Balerdi S; Godwin AK; Leprince D
Oncogene; 2004 May; 23(22):4023-31. PubMed ID: 15007385
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
34. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.
Makos M; Nelkin BD; Reiter RE; Gnarra JR; Brooks J; Isaacs W; Linehan M; Baylin SB
Cancer Res; 1993 Jun; 53(12):2719-22. PubMed ID: 8504410
[TBL] [Abstract][Full Text] [Related]
35. Identification of two candidate tumor suppressor genes on chromosome 17p13.3.
Schultz DC; Vanderveer L; Berman DB; Hamilton TC; Wong AJ; Godwin AK
Cancer Res; 1996 May; 56(9):1997-2002. PubMed ID: 8616839
[TBL] [Abstract][Full Text] [Related]
36. Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.
Hedberg Oldfors C; Dios DG; Linder A; Visuttijai K; Samuelson E; Karlsson S; Nilsson S; Behboudi A
BMC Genet; 2015 Jul; 16():80. PubMed ID: 26170120
[TBL] [Abstract][Full Text] [Related]
37. Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.
De Preter K; Vandesompele J; Menten B; Carr P; Fiegler H; Edsjö A; Carter NP; Yigit N; Waelput W; Van Roy N; Bader S; Påhlman S; Speleman F
BMC Genomics; 2005 Jul; 6():97. PubMed ID: 16000168
[TBL] [Abstract][Full Text] [Related]
38. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
39. Loss of TP53 in sarcomas with 17p12 to approximately p11 gain. A fine-resolution oligonucleotide array comparative genomic hybridization study.
Kaur S; Larramendy ML; Vauhkonen H; Böhling T; Knuutila S
Cytogenet Genome Res; 2007; 116(3):153-7. PubMed ID: 17317953
[TBL] [Abstract][Full Text] [Related]
40. HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.
Britschgi C; Jenal M; Rizzi M; Mueller BU; Torbett BE; Andres AC; Tobler A; Fey MF; Tschan MP
Br J Haematol; 2008 Apr; 141(2):179-87. PubMed ID: 18318772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]